Free Trial

Safe Pro Group (SPAI) Competitors

Safe Pro Group logo
$5.18 +0.06 (+1.17%)
As of 10:28 AM Eastern
This is a fair market value price provided by Massive. Learn more.

SPAI vs. KIDS, CLPT, DCTH, CNXU, and CV

Should you buy Safe Pro Group stock or one of its competitors? MarketBeat compares Safe Pro Group with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with Safe Pro Group include OrthoPediatrics (KIDS), ClearPoint Neuro (CLPT), Delcath Systems (DCTH), Conexeu Sciences (CNXU), and CapsoVision (CV). These companies are all part of the "medical equipment" industry.

How does Safe Pro Group compare to OrthoPediatrics?

Safe Pro Group (NASDAQ:SPAI) and OrthoPediatrics (NASDAQ:KIDS) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their media sentiment, earnings, analyst recommendations, dividends, valuation, institutional ownership, profitability and risk.

OrthoPediatrics has a net margin of -16.31% compared to Safe Pro Group's net margin of -800.91%. OrthoPediatrics' return on equity of -7.01% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
OrthoPediatrics -16.31%-7.01%-4.86%

In the previous week, Safe Pro Group had 6 more articles in the media than OrthoPediatrics. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for OrthoPediatrics. OrthoPediatrics' average media sentiment score of 0.63 beat Safe Pro Group's score of 0.43 indicating that OrthoPediatrics is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Safe Pro Group
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
OrthoPediatrics
0 Very Positive mention(s)
0 Positive mention(s)
2 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Safe Pro Group currently has a consensus target price of $10.00, indicating a potential upside of 93.05%. OrthoPediatrics has a consensus target price of $24.44, indicating a potential upside of 38.73%. Given Safe Pro Group's higher probable upside, analysts plainly believe Safe Pro Group is more favorable than OrthoPediatrics.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
OrthoPediatrics
1 Sell rating(s)
1 Hold rating(s)
8 Buy rating(s)
1 Strong Buy rating(s)
2.82

Safe Pro Group has a beta of 3.28, meaning that its share price is 228% more volatile than the broader market. Comparatively, OrthoPediatrics has a beta of 1.03, meaning that its share price is 3% more volatile than the broader market.

69.1% of OrthoPediatrics shares are held by institutional investors. 54.8% of Safe Pro Group shares are held by company insiders. Comparatively, 31.8% of OrthoPediatrics shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock is poised for long-term growth.

Safe Pro Group has higher earnings, but lower revenue than OrthoPediatrics. OrthoPediatrics is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K177.39-$14.32M-$0.71N/A
OrthoPediatrics$236.35M1.91-$39.65M-$1.68N/A

Summary

Safe Pro Group beats OrthoPediatrics on 9 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to ClearPoint Neuro?

Safe Pro Group (NASDAQ:SPAI) and ClearPoint Neuro (NASDAQ:CLPT) are both small-cap medical equipment companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, institutional ownership, risk, analyst recommendations, profitability, earnings, valuation and media sentiment.

30.1% of ClearPoint Neuro shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by insiders. Comparatively, 6.9% of ClearPoint Neuro shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

Safe Pro Group has a beta of 3.28, indicating that its stock price is 228% more volatile than the broader market. Comparatively, ClearPoint Neuro has a beta of 1.31, indicating that its stock price is 31% more volatile than the broader market.

Safe Pro Group has higher earnings, but lower revenue than ClearPoint Neuro. ClearPoint Neuro is trading at a lower price-to-earnings ratio than Safe Pro Group, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K177.39-$14.32M-$0.71N/A
ClearPoint Neuro$36.97M10.82-$25.54M-$1.01N/A

ClearPoint Neuro has a net margin of -71.57% compared to Safe Pro Group's net margin of -800.91%. Safe Pro Group's return on equity of -119.17% beat ClearPoint Neuro's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
ClearPoint Neuro -71.57%-140.96%-36.98%

In the previous week, Safe Pro Group had 8 more articles in the media than ClearPoint Neuro. MarketBeat recorded 9 mentions for Safe Pro Group and 1 mentions for ClearPoint Neuro. ClearPoint Neuro's average media sentiment score of 1.87 beat Safe Pro Group's score of 0.43 indicating that ClearPoint Neuro is being referred to more favorably in the news media.

Company Overall Sentiment
Safe Pro Group Neutral
ClearPoint Neuro Very Positive

Safe Pro Group currently has a consensus target price of $10.00, indicating a potential upside of 93.05%. ClearPoint Neuro has a consensus target price of $18.00, indicating a potential upside of 34.98%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts clearly believe Safe Pro Group is more favorable than ClearPoint Neuro.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
ClearPoint Neuro
1 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
2.33

Summary

Safe Pro Group beats ClearPoint Neuro on 11 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to Delcath Systems?

Safe Pro Group (NASDAQ:SPAI) and Delcath Systems (NASDAQ:DCTH) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two businesses based on the strength of their institutional ownership, valuation, risk, media sentiment, profitability, dividends, earnings and analyst recommendations.

Delcath Systems has a net margin of 0.62% compared to Safe Pro Group's net margin of -800.91%. Delcath Systems' return on equity of 0.51% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Safe Pro Group-800.91% -119.17% -107.17%
Delcath Systems 0.62%0.51%0.46%

Safe Pro Group currently has a consensus target price of $10.00, suggesting a potential upside of 93.05%. Delcath Systems has a consensus target price of $22.50, suggesting a potential upside of 88.52%. Given Safe Pro Group's stronger consensus rating and higher possible upside, equities analysts plainly believe Safe Pro Group is more favorable than Delcath Systems.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80
Delcath Systems
2 Sell rating(s)
0 Hold rating(s)
5 Buy rating(s)
0 Strong Buy rating(s)
2.43

In the previous week, Safe Pro Group had 7 more articles in the media than Delcath Systems. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for Delcath Systems. Delcath Systems' average media sentiment score of 0.94 beat Safe Pro Group's score of 0.43 indicating that Delcath Systems is being referred to more favorably in the news media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Safe Pro Group
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral
Delcath Systems
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive

Safe Pro Group has a beta of 3.28, meaning that its share price is 228% more volatile than the broader market. Comparatively, Delcath Systems has a beta of 0.54, meaning that its share price is 46% less volatile than the broader market.

Delcath Systems has higher revenue and earnings than Safe Pro Group. Safe Pro Group is trading at a lower price-to-earnings ratio than Delcath Systems, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Safe Pro Group$610K177.39-$14.32M-$0.71N/A
Delcath Systems$85.23M4.83$2.70M$0.011,193.50

61.1% of Delcath Systems shares are owned by institutional investors. 54.8% of Safe Pro Group shares are owned by insiders. Comparatively, 19.4% of Delcath Systems shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

Delcath Systems beats Safe Pro Group on 10 of the 17 factors compared between the two stocks.

How does Safe Pro Group compare to Conexeu Sciences?

Conexeu Sciences (NASDAQ:CNXU) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, media sentiment, profitability and valuation.

Conexeu Sciences has a net margin of 0.00% compared to Safe Pro Group's net margin of -800.91%. Conexeu Sciences' return on equity of 0.00% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
Conexeu SciencesN/A N/A N/A
Safe Pro Group -800.91%-119.17%-107.17%

In the previous week, Safe Pro Group had 6 more articles in the media than Conexeu Sciences. MarketBeat recorded 9 mentions for Safe Pro Group and 3 mentions for Conexeu Sciences. Conexeu Sciences' average media sentiment score of 0.44 beat Safe Pro Group's score of 0.43 indicating that Conexeu Sciences is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
Conexeu Sciences
0 Very Positive mention(s)
0 Positive mention(s)
1 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Neutral
Safe Pro Group
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

Conexeu Sciences has higher earnings, but lower revenue than Safe Pro Group.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Conexeu SciencesN/AN/AN/AN/AN/A
Safe Pro Group$610K177.39-$14.32M-$0.71N/A

Safe Pro Group has a consensus price target of $10.00, indicating a potential upside of 93.05%. Given Safe Pro Group's stronger consensus rating and higher probable upside, analysts clearly believe Safe Pro Group is more favorable than Conexeu Sciences.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Conexeu Sciences
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80

Summary

Safe Pro Group beats Conexeu Sciences on 6 of the 10 factors compared between the two stocks.

How does Safe Pro Group compare to CapsoVision?

CapsoVision (NASDAQ:CV) and Safe Pro Group (NASDAQ:SPAI) are both small-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, valuation, analyst recommendations, media sentiment, institutional ownership, earnings, dividends and profitability.

CapsoVision currently has a consensus price target of $8.50, indicating a potential upside of 20.06%. Safe Pro Group has a consensus price target of $10.00, indicating a potential upside of 93.05%. Given Safe Pro Group's stronger consensus rating and higher possible upside, analysts plainly believe Safe Pro Group is more favorable than CapsoVision.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
CapsoVision
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
1 Strong Buy rating(s)
2.50
Safe Pro Group
1 Sell rating(s)
1 Hold rating(s)
1 Buy rating(s)
2 Strong Buy rating(s)
2.80

CapsoVision has a net margin of -198.87% compared to Safe Pro Group's net margin of -800.91%. CapsoVision's return on equity of 0.00% beat Safe Pro Group's return on equity.

Company Net Margins Return on Equity Return on Assets
CapsoVision-198.87% N/A -136.03%
Safe Pro Group -800.91%-119.17%-107.17%

In the previous week, Safe Pro Group had 7 more articles in the media than CapsoVision. MarketBeat recorded 9 mentions for Safe Pro Group and 2 mentions for CapsoVision. CapsoVision's average media sentiment score of 1.32 beat Safe Pro Group's score of 0.43 indicating that CapsoVision is being referred to more favorably in the media.

Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment
CapsoVision
0 Very Positive mention(s)
1 Positive mention(s)
0 Neutral mention(s)
0 Negative mention(s)
0 Very Negative mention(s)
Positive
Safe Pro Group
2 Very Positive mention(s)
0 Positive mention(s)
4 Neutral mention(s)
0 Negative mention(s)
2 Very Negative mention(s)
Neutral

Safe Pro Group has lower revenue, but higher earnings than CapsoVision. Safe Pro Group is trading at a lower price-to-earnings ratio than CapsoVision, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
CapsoVision$13.55M26.10-$25.32M-$2.34N/A
Safe Pro Group$610K177.39-$14.32M-$0.71N/A

Summary

Safe Pro Group beats CapsoVision on 8 of the 13 factors compared between the two stocks.

Get Safe Pro Group News Delivered to You Automatically

Sign up to receive the latest news and ratings for SPAI and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding SPAI and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SPAI vs. The Competition

MetricSafe Pro GroupTechnology Services IndustryBusiness SectorNASDAQ Exchange
Market Cap$108.17M$4.43B$6.76B$12.31B
Dividend YieldN/A2.12%3.11%5.66%
P/E Ratio-7.2945.3629.4924.76
Price / Sales177.3951.03402.05168.32
Price / CashN/A39.1123.1137.92
Price / Book6.174.785.826.90
Net Income-$14.32M$31.79M$203.78M$337.45M
7 Day Performance-8.16%2.25%1.75%2.84%
1 Month Performance19.08%1.61%3.35%4.78%
1 Year Performance72.09%30.31%38.17%33.08%

Safe Pro Group Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SPAI
Safe Pro Group
3.6417 of 5 stars
$5.18
+1.2%
$10.00
+93.1%
+70.1%$108.17M$610KN/A11
KIDS
OrthoPediatrics
3.0394 of 5 stars
$18.49
+1.4%
$24.44
+32.2%
-15.8%$468.24M$236.35MN/A200
CLPT
ClearPoint Neuro
2.637 of 5 stars
$13.59
+1.6%
$18.00
+32.5%
+16.5%$401.26M$36.97MN/A110
DCTH
Delcath Systems
2.7667 of 5 stars
$11.69
+6.9%
$22.50
+92.5%
-23.6%$377.67M$85.23M1,169.0060
CNXU
Conexeu Sciences
N/A$13.94
-8.7%
N/AN/A$352.26MN/AN/A4

Related Companies and Tools


This page (NASDAQ:SPAI) was last updated on 6/15/2026 by MarketBeat.com Staff.
From Our Partners